EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieStudienprotokollOpen Access

Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator–Delivered Integrated Prevention Package (HPTN 112-NJIRA Study)

Sarah E Rutstein iD, Laura Limarzi-Klyn iD, Jane S Chen iD, Yaw O Agyei iD, Shahnaz Ahmed iD, Ian Bell iD, Myron Cohen iD, Jessica M Fogel iD, Vivian Go iD, Dan Haines iD, Erica L Hamilton iD, Irving F Hoffman iD und 8 weitere

JMIR Research Protocols · 18.06.2025 · 14 · e72981

DOI: 10.2196/72981 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, online erschienen am 18.06.2025. Verfasst von Sarah E Rutstein und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States. Hauptthemen laut MEDLINE: HIV Infections, Pre-Exposure Prophylaxis, Heterosexuality, Sexually Transmitted Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Preexposure prophylaxis (PrEP) remains one of the most efficacious interventions for preventing HIV, but its effectiveness is often limited by poor persistence. Although regional efforts have primarily focused on young women and men who have sex with men, heterosexual men in East and Southern Africa represent a crucial group to engage and retain in PrEP care—both to improve health outcomes for men and to interrupt HIV transmission chains. Men seeking sexually transmitted infection (STI) services are particularly vulnerable to HIV acquisition, yet only a few interventions have tested strategies for engaging and retaining these men in PrEP services. Systems navigation, which addresses barriers to health care access and enhances comfort in clinical settings, may offer a promising approach to improving persistent PrEP use among heterosexual men.

Objective

This study will assess the effect of a peer-delivered systems navigator–facilitated HIV prevention package on PrEP persistence at 26 weeks among heterosexual men seeking STI clinical services in Lilongwe, Malawi. It will also evaluate the acceptability of the intervention and barriers to implementation among key stakeholders. Insights will inform the feasibility of a future randomized controlled trial.

Methods

In this single-site pilot type I effectiveness-implementation hybrid randomized controlled trial, 200 heterosexual men seeking STI services and initiated on PrEP in Lilongwe, Malawi, will be randomized (1:2) to standard-of-care PrEP services or systems navigator–assisted PrEP care (intervention). Participants will be followed every 13 weeks for at least 26 and up to 52 weeks. PrEP use and engagement in care will be assessed through medical record review and intraerythrocytic tenofovir diphosphate measurement, using objective biomedical analyses via dried blood spot. Primary effectiveness and implementation outcomes include 26-week PrEP persistence (adapted to accommodate daily oral, event-driven oral, or injectable PrEP) and acceptability, respectively. Additional implementation outcomes include feasibility and cost. Exploratory objectives characterize preferences for PrEP modalities, perceived and experienced stigma, and the influence of gender norms on PrEP persistence. All clinical services, including the provision of PrEP and PrEP safety monitoring, are being conducted by the Malawi Ministry of Health.

Results

HPTN (HIV Prevention Trials Network) 112 was funded in November 2023. Study recruitment began in April 2024 and closed in November 2024. As of February 3, 2025, the study has enrolled 199 participants, with follow-up expected through June 2025. No interim analyses were planned; data analysis for primary end points is expected in the summer of 2025.

Conclusions

Improving PrEP use outcomes among heterosexual men in East and Southern Africa is critical to interrupting HIV transmission. This study offers unique insights into a low-resource, potentially scalable intervention, focusing on a group of men at particularly high risk of HIV acquisition—those with recent STIs. The hybrid RCT design addresses clinically relevant effectiveness questions and explores key determinants that will inform future multisite implementation trials. Trial Registration ClinicalTrials.gov NCT06200545; https://clinicaltrials.gov/study/NCT06200545 International Registered Report Identifier (IRRID) DERR1-10.2196/72981

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsPre-Exposure ProphylaxisHeterosexualitySexually Transmitted DiseasesHumansMalawiMaleAdultYoung AdultRandomized Controlled Trials as TopicAnti-HIV Agents

Stichwörter der Autor:innen

HIV preventionbacterial STIheterosexualhybridlong-acting injectablepeerpreexposure prophylaxis

Substanzen

Anti-HIV Agents

Autor:innen und Institutionen

  • Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
  • Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, United States.
  • University of Washington, Department of Biostatistics, HPTN Statistical and Data Management Center, Seattle, WA, United States.
  • Network and Collaborative Research Division, FHI 360, Durham, NC, United States.
  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

ORCID-Profile: Sarah E Rutstein, Laura Limarzi-Klyn, Jane S Chen, Yaw O Agyei, Shahnaz Ahmed, Ian Bell, Myron Cohen, Jessica M Fogel, Vivian Go, Dan Haines, Erica L Hamilton, Irving F Hoffman, Mina C Hosseinipour, Mark A Marzinke, William C Miller, Mathews Mukatipa, Julie Pulerwitz, Hans M L Spiegel, Ting Ye, Mitch Matoga

Förderung

  • NIAID NIH HHS

Zitieren

APA

Rutstein, S. E., Limarzi-Klyn, L., Chen, J. S., Agyei, Y. O., Ahmed, S., Bell, I., Cohen, M., Fogel, J. M., Go, V., Haines, D., Hamilton, E. L., Hoffman, I. F., Hosseinipour, M. C., Marzinke, M. A., Miller, W. C., Mukatipa, M., Pulerwitz, J., Spiegel, H. M. L., Ye, T., & Matoga, M. (2025). Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator–Delivered Integrated Prevention Package (HPTN 112-NJIRA Study). JMIR Research Protocols, 14, e72981. https://doi.org/10.2196/72981

Vancouver

Rutstein SE, Limarzi-Klyn L, Chen JS, Agyei YO, Ahmed S, Bell I, et al. Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator–Delivered Integrated Prevention Package (HPTN 112-NJIRA Study). JMIR Research Protocols. 2025;14:e72981. doi:10.2196/72981

BibTeX
@article{Rutstein2025,
  author = {Rutstein, Sarah E and Limarzi-Klyn, Laura and Chen, Jane S and Agyei, Yaw O and Ahmed, Shahnaz and Bell, Ian and Cohen, Myron and Fogel, Jessica M and Go, Vivian and Haines, Dan and Hamilton, Erica L and Hoffman, Irving F and Hosseinipour, Mina C and Marzinke, Mark A and Miller, William C and Mukatipa, Mathews and Pulerwitz, Julie and Spiegel, Hans M L and Ye, Ting and Matoga, Mitch},
  title = {Improving HIV Prevention Among Heterosexual Men Seeking Sexually Transmitted Infection Services in Malawi: Protocol for a Type I Effectiveness-Implementation Hybrid Randomized Controlled Trial of Systems Navigator–Delivered Integrated Prevention Package (HPTN 112-NJIRA Study)},
  journal = {JMIR Research Protocols},
  year = {2025},
  volume = {14},
  pages = {e72981},
  doi = {10.2196/72981}
}
Kostenlos starten →